GoHealth, Inc. (NASDAQ:GOCO) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of GoHealth, Inc. (NASDAQ:GOCO) have been given a consensus recommendation of “Hold” by the five brokerages that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $5.00.

GOCO has been the topic of a number of recent analyst reports. Noble Financial upgraded shares of GoHealth to a “strong-buy” rating in a research note on Wednesday, April 1st. Weiss Ratings restated a “sell (e+)” rating on shares of GoHealth in a research note on Monday, December 29th. Finally, Freedom Capital lowered shares of GoHealth from a “strong-buy” rating to a “hold” rating in a research note on Monday.

Institutional Investors Weigh In On GoHealth

Institutional investors have recently modified their holdings of the business. Bank of America Corp DE grew its position in GoHealth by 22.8% in the 4th quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock worth $105,000 after purchasing an additional 1,452 shares during the last quarter. Empowered Funds LLC grew its position in GoHealth by 7.7% in the 1st quarter. Empowered Funds LLC now owns 25,008 shares of the company’s stock worth $307,000 after purchasing an additional 1,790 shares during the last quarter. Bridgeway Capital Management LLC grew its position in GoHealth by 8.2% in the 2nd quarter. Bridgeway Capital Management LLC now owns 27,066 shares of the company’s stock worth $150,000 after purchasing an additional 2,058 shares during the last quarter. Geode Capital Management LLC grew its position in GoHealth by 4.3% in the 2nd quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock worth $660,000 after purchasing an additional 4,955 shares during the last quarter. Finally, Barclays PLC grew its position in GoHealth by 10.1% in the 4th quarter. Barclays PLC now owns 81,181 shares of the company’s stock worth $175,000 after purchasing an additional 7,430 shares during the last quarter. Institutional investors own 24.21% of the company’s stock.

GoHealth Price Performance

NASDAQ:GOCO opened at $1.26 on Tuesday. The business’s 50-day moving average is $1.71 and its two-hundred day moving average is $2.74. GoHealth has a 12 month low of $1.22 and a 12 month high of $11.36. The firm has a market capitalization of $36.17 million, a PE ratio of -0.07 and a beta of 1.61.

GoHealth (NASDAQ:GOCO) last issued its quarterly earnings data on Tuesday, March 31st. The company reported ($1.03) EPS for the quarter, topping analysts’ consensus estimates of ($2.69) by $1.66. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. The firm had revenue of $12.64 million for the quarter, compared to analyst estimates of $88.62 million. Equities analysts anticipate that GoHealth will post -5.5 EPS for the current year.

GoHealth Company Profile

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.